Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain

Prior Phase 2/3 studies found that cannabinoids might provide adjunctive analgesia in advanced cancer patients with uncontrolled pain. To assess adjunctive nabiximols (Sativex®), an extract of Cannabis sativa containing two potentially therapeutic cannabinoids (Δ9-tetrahydrocannabinol [27 mg/mL] and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pain and symptom management 2018-02, Vol.55 (2), p.179-188.e1
Main Authors: Lichtman, Aron H., Lux, Eberhard Albert, McQuade, Robert, Rossetti, Sandro, Sanchez, Raymond, Sun, Wei, Wright, Stephen, Kornyeyeva, Elena, Fallon, Marie T.
Format: Article
Language:English
Subjects:
advanced cancer pain
Analgesia
Anesthesia
Cancer
cannabinoids
Chronic pain
Clinical trials
Dosage
Double-blind studies
Drug therapy
Efficacy
Marijuana
Measures
Medical marijuana
Medical treatment
nabiximols
numerical rating scale
Opioids
Pain
Pain management
Pain Medicine
Pathophysiology
Patients
Placebo effect
Quality of life
randomized control trial
Ratings & rankings
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!